Judge Nixes Rule Forcing Drug Prices In TV Ads

Law360 (July 8, 2019, 6:45 PM EDT) -- A D.C. federal judge on Monday vacated a federal regulation mandating the disclosure of wholesale drug prices in television advertisements, a decision that came just the day before the controversial requirement was set to take effect.

Wholesale drug prices don't have to be revealed in TV ads, a judge has ruled. (AP) U.S. District Judge Amit P. Mehta said the wholesale acquisition cost disclosure rule was invalid and set it aside, handing a win to three drugmakers that filed the suit: Amgen Inc., Eli Lilly & Co. and Merck & Co. Inc. Experts previously told Law360 that the rule was on shaky...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS